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abdominal aortic aneurysm repair and external
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Nicholas Boyne, MBBS, FRACS (Vasc),c Allan Kruger, MBBS, FRACS (Vasc),c and Philip J. Walker,
MBBS, FRACS (Vasc),a,c,d Brisbane, Queensland and Adelaide, South Australia, Australia
Introduction: Endovascular abdominal aortic aneurysm (AAA) repair (EVAR) has been associated with lower operative
mortality and morbidity than open surgery but comparable long-term mortality and higher delayed complication and
reintervention rates. Attention has therefore been directed to identifying preoperative and operative variables that
influence outcomes after EVAR. Risk-predictionmodels, such as the EVARRisk Assessment (ERA)model, have also been
developed to help surgeons plan EVAR procedures. The aims of this study were (1) to describe outcomes of elective EVAR
at the Royal Brisbane and Women’s Hospital (RBWH), (2) to identify preoperative and operative variables predictive of
outcomes after EVAR, and (3) to externally validate the ERA model.
Methods: All elective EVAR procedures at the RBWH before July 1, 2009, were reviewed. Descriptive analyses were
performed to determine the outcomes. Univariate and multivariate analyses were performed to identify preoperative and
operative variables predictive of outcomes after EVAR. Binomial logistic regression analyses were used to externally
validate the ERA model.
Results: Before July 1, 2009, 197 patients (172 men), who were a mean age of 72.8 years, underwent elective EVAR at
the RBWH. Operative mortality was 1.0%. Survival was 81.1% at 3 years and 63.2% at 5 years. Multivariate analysis
showed predictors of survival were age (P .0126), American Society of Anesthesiologists (ASA) score (P .0180), and
chronic obstructive pulmonary disease (P  .0348) at 3 years and age (P  .0103), ASA score (P  .0006), renal failure
(P .0048), and serum creatinine (P .0022) at 5 years. Aortic branch vessel score was predictive of initial (30-day) type
II endoleak (P  .0015). AAA tortuosity was predictive of midterm type I endoleak (P  .0251). Female sex was
associated with lower rates of initial clinical success (P  .0406). The ERA model fitted RBWH data well for early death
(C statistic  .906), 3-year survival (C statistic  .735), 5-year survival (C statistic  .800), and initial type I endoleak
(C statistic  .850).
Conclusions: The outcomes of elective EVAR at the RBWH are broadly consistent with those of a nationwide Australian
audit and recent randomized trials. Age and ASA score are independent predictors of midterm survival after elective
EVAR. The ERA model predicts mortality-related outcomes and initial type I endoleak well for RBWH elective EVAR
patients. ( J Vasc Surg 2011;54:644-53.)
r
i
c
A
fi
p
u
d
s
A
u
S
d
a
s
e
e
T
t
pEndovascular abdominal aortic aneurysm (AAA) repair
(EVAR) is a minimally invasive option for the manage-
ment of AAA. Unfortunately, the randomized trials com-
paring elective open repair and EVAR1-6 have failed to
demonstrate a long-term survival benefit for EVAR.
Most of these trials also showed that EVAR was associ-
ated with high delayed complication and reintervention
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644ates. Several authors have conducted research into the
nfluence of preoperative and operative variables on out-
omes after EVAR, with the ultimate aim of identifying
AA patients for whom EVAR will offer a clear bene-
t compared with open surgery. Computerized risk-
rediction models, in which preoperative variables are
sed to predict post-EVAR outcomes, have also been
eveloped to assist vascular surgeons with clinical deci-
ion making.
An example of such a model is the Endovascular Risk
ssessment (ERA) model (Fig 1),7 developed in Australia,
sing data from a nationwide EVAR audit, the Australian
afety and Efficacy Register of New Interventional Proce-
uresSurgical (ASERNIP-S) audit. The model is freely
vailable online (http://www.health.adelaide.edu.au/
urgery/evar). Up to eight preoperative variables can be
ntered into the model, which will provide probability
stimates with confidence intervals for a range of outcomes.
he model has been externally validated using data from
he St. George’s Hospital in the United Kingdom and
redicted mortality-related outcomes and midterm type I
ndoleak well for these patients.8
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Volume 54, Number 3 Wisniowski et al 645EVAR has been performed at the Royal Brisbane and
Women’s Hospital (RBWH) since 1994. We used RBWH
data to conduct an observational study with the aims of (1)
describing the outcomes of elective EVAR at the RBWH,
(2) identifying preoperative and operative variables predic-
tive of outcomes after elective EVAR, and (3) externally
validating the ERA model.
METHODS
Data collection. As part of the routine practice of the
RBWH Department of Vascular Surgery, data for all
RBWH elective EVAR cases (excluding data pertaining to
the morphology of the AAA) are collected prospectively on
an Excel database (Microsoft Corp, Redmond, Wash),
including data from data sheets completed during the
primary admission (Appendix A, online only). Data for all
patients from this database who underwent elective EVAR
at the RBWH before July 1, 2009, were extracted for this
study for statistical analysis.
RBWH elective EVAR patients routinely undergo
computed tomography angiography (CTA) as part of their
preoperative evaluation. These images were analyzed to
gather detailed information on the morphology of each
patient’s aortoiliac vasculature. Morphologic variables of
interest, and the methods used to measure them, are de-
scribed in Table I. CTA images were displayed digitally,
and electronic calipers were used to take all measurements.
One observer assessed each morphologic variable at least
once. Assessment of morphologic variables was repeated in
a blinded fashion for 20 patients to determine intraobserver
reliability. Measurements were taken, where possible, using
methods recommended by the Ad Hoc Committee for
Standardised Reporting Practices in Vascular Surgery.9,10
Mortality data were sourced for all patients. The
RBWH Hospital-Based Clinical Information System
Fig 1. The endovascular aneurysm repair (EVAR) Risk A
Anesthesiologists (score).7(HBCIS) was first consulted to determine deaths known to oheRBWH.TheQueenslandHealth Integration andLinkage
nit provided mortality data for the remaining patients.
Outcome measures and definitions. The key out-
omes of interest for this research project and their defini-
ions are described in Table II. Additional outcomes of
nterest not listed in Table II relate to systemic complica-
ions (eg, sepsis, pneumonia) occurring 30 days of
VAR.
Statistical analysis. With the exception of the ERA
odel fitting, statistical analyses were performed using SAS
oftware (SAS Institute Inc, Cary, NC). Basic descriptive
nalyses were used to determine the outcomes of elective
VAR at the RBWH. Univariate analyses (2 tests, Fisher
xact tests, and two-sample homoscedastic t tests) were
erformed to investigate the influence of preoperative and
perative variables on post-EVAR outcomes. Multivariate
nalyses (binomial logistic regressions) were subsequently
erformed using those preoperative and operative variables
hat had significantly influenced post-EVAR outcomes on
nivariate analysis.
The fitting of the RBWH data to the ERA model was
erformed using S-PLUS statistical software (TIBCO Soft-
are Inc, Palo Alto, Calif). The goodness-of-fit of the
BWH data was assessed via binomial logistic regressions
sing Frank Harrell’s Design Library.11
ESULTS
Outcomes of elective EVAR at the RBWH. Before
uly 1, 2009, 197 patients underwent elective EVAR at the
BWH, with the first procedure performed in 1994. The
linical status of the cohort at the time of EVAR is pre-
ented in Table III, and aneurysm morphology data are
resented in Table IV. The cohort was a mean age of 72.8
ears (SD, 7.5 years), men accounted for 87.3% of patients,
nd 68.4% of patients were American Society of Anesthesi-
ment (ERA) model interface.ASA, American Society ofssesslogists (ASA) 3. The most common comorbidities were
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September 2011646 Wisniowski et alhypertension (71.4%) and ischemic heart disease (57.1%),
and 92% of patients were current or former smokers. The
mean (SD) AAA diameter was 54.6 (10.3) cm on axial
images and 55.1 (10.5) cm on sagittal images. All methods
used to assess morphologic variables had adequate intra-
observer reliability (Appendix C, online only).
Details of the elective EVAR procedures performed at
the RBWH are provided in Table V. Most patients (84.2%)
received general anesthesia. The most commonly used
stent grafts were the Talent (Medtronic, Minneapolis,
Minn) and Zenith (Cook, Bloomington, Ind) devices.
The results of elective EVAR at the RBWH are sum-
marized in Table VI. Two operative deaths, which were also
the only aneurysm-related deaths, occurred in 1994 and
2009, for an operative mortality of 1.0%. The first of these
was an 80-year-old woman who was one of the earliest
EVAR cases at the RBWH. A rupture occurred on postop-
erative day 2, possibly related to a distal type I endoleak
around the iliac attachment. She had a nodular cirrhotic
liver, and despite urgent open repair, there was ongoing
coagulopathy and the patient died early the next day. The
second death occurred in an 87-year-old man who devel-
oped a large retroperitoneal hematoma postoperatively,
probably related to access vessel injury during initial de-
ployment. This patient, who was a Jehovah’s Witness, was
potentially salvageable but he refused any blood products
or further intervention and died on postoperative day 3.
The survival rates were 81.1% at 3 years and 63.2% at 5
years. Fig 2 shows a Kaplan-Meier survival curve for the
Table I. Morphologic variables and measurement method
Region and variable CTA image used
Infrarenal aortic neck
Diameter Axial M
Length 3D reconstructions Di
Angulation 3D reconstructions An
Thrombus Axial Sc
AAA
Diameterb Axial M
Sagittal Pe
Tortuosity 3D reconstructions Ca
Iliac arteries
Thrombus Axial Sc
Aortic branch vessels Axial Sc
Tortuosity 3D reconstructions Ca
Calcificatione 3D reconstructions Sc
AAA, Abdominal aortic aneurysm; CTA, computed tomography angiograp
aThe outer adventitia of the vessel wall was used as a reference point.
bAAA diameter was assessed on axial and sagittal CTA images.
cL1 is the distance along the centerline of the vessel between the lowermost
these points.
dL1 is the distance along the centerline of the vessel between the aortic bifu
distance between these points.
eCalcification scores were calculated for common and external iliac artery seRBWH elective EVAR patient cohort. oAt least one initial graft-related complication occurred
n 57 patients (28.9%), nearly all of which were type II
ndoleaks. Eight patients (4.1%) underwent nine initial
einterventions, most commonly for type I endoleak. After
ischarge, 18 graft-related complications occurred in 14
atients (7.1%). There were no midterm ruptures.
wenty midterm reinterventions were required in 14
atients (7.1%), with 12 of these for type I or II en-
oleak. Graft-related complication and reintervention
utcomes are listed in Table VII, with details provided in
ppendix D (online only). With respect to composite
nd points, technical success was achieved in 98.5% of
ases, and 94.4% of patients satisfied the criteria for
nitial clinical success.
Predictors of outcome for the RBWH elective
VAR patient cohort. Preoperative and operative vari-
bles predictive of post-EVAR outcomes on univariate and
ultivariate analysis are presented in Tables VIII and IX,
espectively. Multivariate analysis showed predictors of
-year survival were age, ASA score, and chronic obstruc-
ive pulmonary disease (COPD), whereas predictors of
-year survival were age, ASA score, renal failure, and serum
reatinine level. With respect to morbidity-related out-
omes, aortic branch vessel score was predictive of initial
ype II endoleak, and AAA tortuosity was predictive of
idterm type I endoleak. Sex was predictive of initial
linical success.
Fitting of RBWH elective EVAR patients to the
RAmodel. Table X summarizes the results of the goodness-
Measurement method
xis of the ellipse on first axial slice below lowermost renal arterya
e along centerline of vessel from lowermost renal artery to the
ning of the AAA
etween the long axis of the neck and long axis of the AAA
as 0  thrombus 25%; 1  thrombus 25%-50%; 2  thrombus
of luminal area
xis of ellipse on axial slice in which AAA area is maximala
icular to centerline of flowa
ted using the formula T  [L1/L2]
c
as 0  no thrombus; 1  thrombus 25%; 2  thrombus 25%-
3  thrombus 50% of luminal area
as 0  no vessels; 1  1 lumbar artery or IMA; 2  2 vessels
ssels 4 mm in diameter); 3  2 vessels with IMA 4 mm in
ter
ted using the formula T  L1/L2
d
as follows: 0  no calcification; 1  calcification  25%; 2 
cation 25%-50%; 3  calcification 50% of vessel length
A, inferior mesenteric artery.
rtery and the aortic bifurcation, and L2 is the straight line distance between
n and the origin of the common femoral artery, and L2 is the straight line
ts bilaterally.s10
inor a
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Volume 54, Number 3 Wisniowski et al 647early death, survival at 3 and 5 years, and initial type I
endoleak, as evidenced by C statistics of .70. With the
exception of initial type I endoleak, the model did not
perform well for morbidity-related outcomes.
DISCUSSION
Outcomes of elective EVAR at the RBWH. The
outcomes of elective EVAR at the RBWH were broadly
consistent with those of the ASERNIP-S audit and ran-
domized trials comparing open and endovascular repair.
Early death occurred in 1.0% of RBWH patients, compared
Table II. Key outcomes of interest after abdominal
aortic aneurysm (AAA) repair
Outcome Definition
Mortality outcomes
Early death Deaths occurring 30 days of
procedure
Operative death Deaths occurring 30 days of
procedure or during the
primary hospital admission
3-year survival Survival 3 years after
procedure
5-year survival Survival 5 years after
procedure
ARD Deaths 30 days of a primary
or secondary procedure for
the AAA, or deaths due to
AAA rupture
Morbidity outcomes
Complications
Initial Any graft-related complication
(eg, endoleaks I–V,
migration, thrombosis)
occurring before discharge
Midterm graft-related As above, occurring after
discharge
Type I endoleak
Initial Type I endoleaks occurring
30 days of procedure
Midterm Type I endoleaks occurring
30 days after the
procedure
Type II endoleak
Initial Type II endoleaks occurring
30 days of procedure
Midterm Type II endoleaks occurring
30 days after the
procedure
Reinterventions
Initial Reinterventions occurring
before discharge
Midterm Reinterventions occurring
after discharge
Composite outcomes
Technical success9 See Appendix Ba
Initial clinical success9 30 days of procedure; see
Appendix Ba
ARD, Aneurysm-related death.
aAppendix B is available online only.with 1.8% of the ASERNIP-S audit patients7 and 0.2% to (.7% of patients in the randomized trials.2,4-6 Survival rates
t 3 and 5 years were also remarkably similar for RBWH
81.1% and 63.2%, respectively) and ASERNIP-S audit
atients (80.5% and 67.7%, respectively).7 With respect to
orbidity-related outcomes, initial type II endoleaks were
ommon among RBWH patients (24.4%), but initial type
I endoleaks occurred in only 7.0% of the ASERNIP-S
udit patients.7 There are several potential reasons for the
igh endoleak rate. At the RBWH, type II endoleaks were
rst assessed on the completion angiogram. Because many
ype II endoleaks resolve spontaneously,12 events may be
issed if assessment for type II endoleak does not occur
ntil after the completion angiogram. In addition, more
han half of the RBWH cohort had aortic branch vessel
cores of 3, indicating the presence of multiple patent
ranchvessels. Patent inferiormesenteric artery (IMA),13-15 pat-
nt IMA diameter,14 and patent lumbar artery number13,14
ave all been associated with an increased risk of type II
ndoleak.
Despite the high initial rate of type II endoleak among
BWH patients, the initial reintervention rate was low
able III. Clinical status of the Royal Brisbane and
omen’s Hospital elective endovascular aneurysm repair
atient cohort at the time of the primary procedure
linical variable Resulta
Missing
data (No.)
ge (years) 0
Mean (SD) median 72.8 (7.5) 73
ale sex 172 (87.3) 0
omorbidity status
SA score
1 0 (0) 4
2 38 (19.7)
3 132 (68.4)
4 23 (11.9)
reatinine, mol/L 2
Mean (SD) median 105.8 (60.9) 90
ypertension 140 (71.4) 1
iabetes 36 (18.4) 1
VD 53 (27) 1
HD 112 (57.1) 1
CF 7 (3.6) 1
troke 19 (9.7) 1
IA 10 (5.1) 1
OPD 39 (19.9) 1
sthma 15 (7.6) 1
enal failureb
No dialysis required 21 (10.7) 1
Dialysis required 1 (0.5) 1
moking status
Current smoker 30 (15.4) 2
Former smoker 150 (76.9)
Never smoked 15 (7.7)
CF, Congestive cardiac failure; COPD, chronic obstructive pulmonary
isease; IHD, ischemic heart disease; PVD, peripheral vascular disease; SD,
tandard deviation; TIA, transient ischemic attack.
Results displayed as frequency number (percentage) unless otherwise indi-
ated.
Defined as serum creatinine 120 mol/L.4.1%) because the type II endoleaks were observed rather
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September 2011648 Wisniowski et althan treated. The RBWH initial reintervention rate was far
lower than that reported by the ASERNIP-S audit (31.1%),
but comparable to other reported rates. For example, only
Table IV. Morphologic status of the Royal Brisbane and
Women’s Hospital elective endovascular aneurysm repair
patient cohort at the time of the primary procedure
Morphologic variable Result
Missing
data (No.)
Infrarenal neck
Diameter, cm 29
Mean (SD) median 23.2 (3.1) 23
Length, cm 32
Mean (SD) median 37.1 (14.1) 37
Angulation, deg 57
Mean (SD) median 35.2 (16.5) 35
Thrombus, No. (%) 32
0 154 (93.3)
1 11 (6.7)
2 0 (0)
AAA
Axial diameter, cm 3
Mean (SD) median 54.6 (10.3) 52
Sagittal diameter, cm 3
Mean (SD) median 55.1 (10.5) 53
Thrombus, No. (%) 32
0 12 (7.3)
1 31 (18.8)
2 47 (28.5)
3 75 (45.4)
Tortuosity 60
Mean (SD) median 1.10 (0.07) 1.08
Branch vessels, No. (%) 34
0 22 (13.5)
1 24 (14.7)
2 31 (19.0)
3 86 (52.8)
Iliac arteries
Ipsilateral tortuosity 72
Mean (SD) median 1.33 (0.16) 1.30
Contralateral tortuosity 72
Mean (SD) median 1.31 (0.17) 1.28
Calcification
Ipsilateral CIA, No. (%) 59
0 2 (1.4)
1 31 (22.5)
2 20 (14.5)
3 85 (61.6)
Ipsilateral EIA, No. (%) 73
0 12 (9.7)
1 88 (71.0)
2 12 (9.7)
3 12 (9.7)
Contralateral CIA, No. (%) 59
0 2 (1.4)
1 34 (24.6)
2 12 (13.8)
3 83 (60.1)
Contralateral EIA, No. (%) 73
0 12 (9.7)
1 86 (69.3)
2 15 (12.1)
3 11 (8.9)
CIA,Common iliac artery; EIA, external iliac artery; SD, standard deviation.2.7% of EVAR patients in a large observational study by bchermerhorn et al16 required an aneurysm-related reinter-
ention 1 year.
Graft-related complication and reintervention rates
ere similarly low among RBWH patients at midterm.
otably, only 2.5% of RBWH patients had a midterm type
I endoleak compared with 14.1% of the ASERNIP-S audit
atients, despite the high initial type II endoleak rate. This
mplies that approximately 89.6% of initial type II en-
oleaks among RBWH patients resolved spontaneously.
his is consistent with the findings of Jones et al,12 who
eported that 79.9% of type II endoleaks identified on early
ostoperative imaging (day 1) had resolved 6 months.
Predictors of outcome after elective EVAR at the
BWH. The study did not identify any variables indepen-
ently predictive of early death or aneurysm-related death
ARD) because there were very few of these events among
BWH patients. In contrast, several variables were inde-
endently associated with reduced midterm survival after
VAR. Age and ASA score were independently predictive
f midterm survival at 3 and 5 years. These associations
ere expected and have been reported previously.17-21
evertheless, the influence of the ASA score on midterm
urvival among RBWH patients was notably strong, with
-year survival rates for ASA 2, 3, and 4 individuals of
0.5%, 64.3%, and 23.1%, respectively. Similarly, Boult et
l17 found the ASA score was the most powerful predictor
f midterm survival among the ASERNIP-S audit patients.
Other variables independently predictive of midterm
urvival among RBWH patients included COPD, associ-
ted with reduced 3-year survival, and renal failure and
erum creatinine, associated with reduced 5-year survival.
he inability of this study to demonstrate an effect of
OPD on 5-year survival was possibly because only 39
atients (19.8%) had COPD. The difference in survival
able V. Details of elective endovascular aneurysm
epair at the Royal Brisbane and Women’s Hospital
rocedural variable
Results
No. (%)
Missing
data (No.)
nesthetic 1
General 165 (84.2)
Epidural 11 (5.6)
Spinal 4 (2.0)
Local 2 (1.0)
Epidural and general 9 (4.6)
Epidural and spinal 5 (2.6)
tent graft 0
Talenta 133 (67.5)
Zenithb 47 (23.9)
AneuRxa 8 (4.1)
Enduranta 4 (2.0)
Other 5 (2.5)
tent graft configuration 0
Bifurcated 183 (92.9)
Tubular 9 (4.6)
Aortouniiliac 5 (2.5)
Medtronic, Minneapolis, Minn.
Cook, Bloomington, Ind.etween patients with and without COPD did not increase
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Volume 54, Number 3 Wisniowski et al 649between 3 (17.2%) and 5 years (17.9%) after EVAR, as
might be expected, a finding that implicates the small
sample size. Similarly, this study was not able to demon-
strate an effect of renal failure on 3-year survival probably
because only 21 patients (10.7%) had this condition, and
almost all of these patients had only relatively modest rises
in serum creatinine (120-160 mol/L).
The aortic branch vessel score was an independent
predictor of initial type II endoleak in this study. RBWH
patients with aortic branch vessel scores of 0, 1, 2, and 3
had initial type II endoleak rates of 0%, 20.8%, 29%, and
Table VI. Results of elective endovascular aneurysm repair
performed at the Royal Brisbane and Women’s Hospital
Outcome Result No. (%)
Mortality outcomes
Early death 2 (1.0)
Operative death 2 (1.0)
3-year survival 133 (81.1)
5-year survival 67 (63.2)
Aneurysm-related death 2 (1.0)
Morbidity outcomes—local
Graft-related complications
Initiala 57 (28.9)
Midtermb 14 (7.1)
Endoleak
Initial type I 3 (1.5)
Midterm type I 5 (2.5)
Initial type II 48 (24.4)
Midterm type II 5 (2.5)
Reinterventions
Initialc 8 (4.1)
Midtermd 14 (7.1)
Morbidity outcomes—systemice
Myocardial infarction 4 (2.0)
Congestive cardiac failure 2 (1.0)
Cardiac arrest 2 (1.0)
Arrhythmia 6 (3.1)
Pneumonia 1 (0.5)
Deep vein thrombosis 0 (0)
Pulmonary embolism 0 (0)
Ischemic colitis 1 (0.5)
Acute renal failure
Not requiring dialysis 2 (1.0)
Requiring dialysis 0 (0)
Transient ischemic attack 0 (0)
Stroke 0 (0)
Blood transfusion 5 (2.5)
Bleeding requiring
reoperation
3 (1.5)
SIRS 1 (0.5)
Sepsis 0 (0)
Limb ischemia 1 (0.5)
Amputation 0 (0)
Composite outcomes
Technical success 194 (98.5)
Initial clinical success 186 (94.4)
SIRS, Systemic inflammatory response syndrome.
a57 patients had 58 initial graft-related complications.
b14 patients had 18 midterm graft-related complications.
c8 patients had 9 initial reinterventions.
d14 patients had 20 midterm reinterventions.
eOccurring 30 days of the primary procedure36.1%, respectively. To our knowledge, this is the first .tudy to demonstrate the utility of aortic branch vessel
core in predicting type II endoleak. Although the aortic
ranch vessel score was not predictive of midterm type II
ndoleak in this study, only five of these events occurred
mong RBWH patients. Given that several authors22-24
ave considered type II endoleaks benign unless they are
ssociated with sac expansion, research into the utility of
he aortic branch vessel score in predicting sac expansion
ay be worthwhile.
The aortic tortuosity index was independently predic-
ive of midterm type I endoleak among RBWH patients.
he utility of the aortic tortuosity index in predicting
ost-EVAR outcomes has not, to our knowledge, been
nvestigated previously. Some authors, however, have in-
estigated similar measures; for example, Whittaker et al25
eported an association between increased aortoiliac tortu-
sity and deployment problems with the Excluder (W. L.
ore and Associates, Flagstaff, Ariz) device.
Female sex was independently associated with a de-
reased likelihood of initial clinical success in this study.
our of the 11 instances where initial clinical success was
ot achieved occurred in women. These included one AAA
upture, two type I endoleaks, and an access vessel injury
hat resulted in a false aneurysm, all requiring additional
rips to the operating theater. Given the low number of
vents, this may be a chance finding. Although there has
een very little use of this outcome measure in the pub-
ished literature, Boult et al26 reported an aortic neck angle
45° was associated with reduced initial clinical success.
Procedural variables, including brand of device, device
onfiguration, and anesthesia type did not influence post-
VAR outcomes among RBWHpatients. This was possibly
ecause RBWH patients generally received similar treat-
ent, with 91.4% of patients receiving Talent (Medtronic)
r Zenith (Cook) stent grafts, 92.9% of patients receiving
ifurcated devices, and 84.2% of patients receiving general
nesthesia. The comparable performance of the Talent and
enith stent grafts in this study echoes the findings of
rown et al,27 who found no difference in performance
etween the two devices on analysis of the Endovascular
neurysm Repair 1 (EVAR 1) and Endovascular Aneurysm
epair 2 (EVAR 2) trial results.
Fitting of RBWH data to the ERA model. The
BWH data fitted the ERA model well for mortality-
elated outcomes, which is not surprising given the high
oncordance in post-EVAR survival between the RBWH
nd ASERNIP-S audit patients. C statistics for early death,
-year survival, and 5-year survival were all .70, which is
ommonly considered the threshold value for acceptable
iscriminative ability of risk prediction models.28
The ERA model has similarly predicted mortality-
elated outcomes well for patients from St. George’s Hos-
ital in the United Kingdom, even though these patients
ere older and had higher ASA scores and larger aneurysms
han the RBWH patients.8 In contrast, the ERA model did
ot predict morbidity-related outcomes well for RBWH
atients, with the exception of initial type I endoleak (C 
85). Similarly, the ERA model did not perform well with
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Hospital patients, with the exception of midterm type I
endoleak (C  .73).8 There are several potential reasons
Fig 2. Kaplan-Meier curve shows survival for the Ro
aneurysm repair patient cohort. The dotted lines show th
Table VII. Graft-related complication and reintervention
outcomes
Outcome Frequency
In-hospital
Graft-related complications
Type II endoleak 48
Type I endoleak 3
Access vessel problems 3
Rupture 1
Other 3
Total 58
Reinterventions
Type I endoleak 3
Type II endoleak 1
Rupture 1
Other 4
Total 9
Midterm
Complications
Type I endoleak 5
Type II endoleak 5
Graft migration 3
Graft stenosis 2
Other 3
Total 18
Reinterventions
Endoleaks I and II 12
Graft migration 3
Graft stenosis 2
Other 3
Total 20why the ERA model has been less successful in predicting oorbidity-related outcomes. As discussed earlier, rates for
ertain morbidity-related outcomes (eg, initial type II en-
oleaks) are very much influenced by when assessment for
hese outcomes occurs. For outcomes with low event rates,
ery large patient samples would be required to adequately
ssess the ERA model.
Limitations. The study had several limitations. The
tudy was too small to identify variables predictive of out-
omes with low event rates. Being an observational study,
dentified relationships between preoperative and operative
ariables and post-EVAR outcomes could not be indisput-
bly considered cause-and-effect; they were possibly asso-
iations. Furthermore, the study was potentially affected by
bservation bias. For example, it is possible that some
ost-EVAR adverse events were not recorded. Events may
lso have been missed due to follow-up losses. The number
f unrecorded events in this study was arguably lessened
ecause, with the exception of morphologic data, data
ollection was prospective.
Missing morphologic data hampered this study; this
ccurred for several reasons. Preoperative CTAs were not
vailable for patients who received EVAR before the year
000 and for some patients who underwent imaging at
ospitals not affiliated with the RBWH. Some patients did
ot receive 3-dimensional reconstructions, whereas others
eceived scans that did not include the entire iliac vascula-
ure. Because preoperative AAA diameters were recorded
uring the primary admission or were available from radi-
logy reports, these were used where this information was
ot obtainable.
Morphologic variables were assessed, where possible,
sing methods described in published guidelines,10 but in
any cases, the intraobserver and interobserver reliability
risbane and Women’s Hospital elective endovascular
confidence intervals.yal Bf these methods have not been established. However,
Cw
d
s
s
r
R
r
; two-
orderl
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Volume 54, Number 3 Wisniowski et al 651blinded repeat assessment of morphologic variables for a
subset of 20 patients found intraobserver reliability was
acceptable in all cases.
There are potential limitations to the external validity
of this study. The RBWH Department of Vascular Surgery
has generally been conservative in its adoption and applica-
tion of EVAR. Study patients seldom had challenging
anatomy, and few had severe comorbidities. Thus, the
RBWH elective EVAR population was highly selected and
may not be representative of corresponding populations in
Table VIII. Statistically significant results on univariate an
Outcomea Variable
T
vaMortality-related Pre-op or operative
Early death/ARDb Age Con
Serum creatinine Con
3-year survival Age Con
ASA score Cat
COPD Cat
AAA axial diameter Con
AAA sagittal diameter Con
5-year survival Age Con
ASA score Cat
Serum creatinine Con
Renal failure Cat
Renal failure requiring dialysis Cat
AAA diameter (sagittal)e Con
Morbidity-related
Initial type II endoleak Aortic branch vessel score Cat
Midterm type I endoleak Infrarenal neck angulation Con
AAA tortuosity Con
Composite
Initial clinical success Sex Cat
ASA, American Society of Anesthesiologists; ARD, aneurysm-related death
aAll outcome variables were categoric (dichotomous).
bEarly death and ARD are presented together because the two early deaths
cAll t tests were two-sample and were homoscedastic
dFisher exact test was used when 25% of cells had frequency counts of 5
eThe association between AAA diameter (axial) and 5-year survival was of b
Table IX. Statistically significant results on multivariate (b
Outcome variable
Variable (pre-op or
operative) Esti
Mortality-related
3-year survival Age 0.
ASA score 1.
COPD 1.
5-year survival Age 0.
ASA score 1.
Renal failure 2.
Serum creatinine 0.
Morbidity-related
Initial type II endoleak Aortic branch vessel score 0.
Midterm type I endoleak AAA tortuosity 39.
Composite outcomes
Initial clinical success Sex 1.
AAA, Abdominal aortic aneurysm, ASA, American Society of Anaesthesiolo
aDegrees of freedom  1 in all cases.other centers. oONCLUSIONS
The outcomes of elective EVAR at the RBWHcompare
ell with those of the ASERNIP-S audit and recent ran-
omized trials. Age, ASA score, COPD, renal failure, and
erum creatinine were independent predictors of midterm
urvival in this study. The ERA model predicted mortality-
elated outcomes and initial type I endoleaks well for
BWH patients but performed less well for other morbidity-
elated outcomes. Future research into variables predictive
s
e Statistical test
Result
Pt or 2
us t testc t(195)  2.03 .0434
us t test t(193)  4.64 .0001
us t test t(162)  2.83 .0053
2 test 2(2, n  162)  7.4034 .0247
2 test 2(1, n  163)  4.8919 .0270
us t test t(159)  2.84 .0051
us t test t(159)  2.95 .0036
us t test t(104)  2.60 .0107
2 test 2(2, n  104)  15.9159 .0003
us t test t(102)  3.40 .0010
Fisher exact
testd
. . . .0018
Fisher exact test . . . .0018
us t test t(101)  2.02 .0461
al 2 test 2(3, n  163)  12.0370 .0073
us t test t(138)  2.06 .0414
us t test t(135)  3.08 .0025
Fisher exact test . . . .0363
D, chronic obstructive pulmonary disease.
ccurred were the only aneurysm-related deaths.
sided P values are displayed.
ine significance: t(101)  1.95, P  .0537.
ial logistic regression) analysisa
SE Wald 95% CL Wald 2 P
0.0310 0.1380, 0.0166 6.23 .0126
0.4506 1.9489, 0.1827 5.60 .0180
0.4988 2.0305, 0.0753 4.46 .0348
0.0307 0.1388, 0.0186 6.59 .0103
0.5762 3.1187, 0.8600 11.92 .0006
0.7808 3.7312, 0.6706 7.95 .0048
0.0068 0.0342, 0.0075 9.34 .0022
0.2127 0.2575, 1.0913 10.05 .0015
17.6356 4.9440, 74.0743 5.02 .0251
0.7142 2.8618, 0.0623 4.19 .0406
CL, confidence limits; COPD, chronic obstructive pulmonary disease.alysi
ype of
riabl
tinuo
tinuo
tinuo
egoric
egoric
tinuo
tinuo
tinuo
egoric
tinuo
egoric
egoric
tinuo
egoric
tinuo
tinuo
egoric
; COP
that oinom
mate
0773
0658
0529
0787
9894
2009
0208
6744
5092
4620
gists;f post-EVAR outcomes should be prospective, with as-
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1
1
1
1
1
1
1
1
2
2
2
2
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September 2011652 Wisniowski et alsessment of morphologic variables performed using meth-
ods with established intraobserver and interobserver reli-
ability. Further external validation of the ERA model is
indicated and will require large patient samples, given the
low event rates for some post-EVAR outcomes.
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